Wednesday , October 5 2022

Israeli-made app has been proven to reduce blood pressure, studies show


Hello Heart, an Israeli digital therapy company that specializes in heart disease, announces that a new study has revealed that it can acquire and maintain digital digital applications for blood pressure management. Blood pressure increases over time, even for those who are at high risk for heart failure. Illness. More than 84% of participants with stage II hypertension achieved a reduction in their systolic blood pressure, which was sustained for three years, according to a study published in the JAMA Network Open, according to a study by the American Medical Association. Reviewed Journal.

Hello Heart’s Blood Nail Blood Pressure Cuff and smartphone app empower users to manage their heart health and detect serious problems before they occur. Hello Heart, founded in 2013, has been added to follow medication reminders and clinic-based, personalized digital coaching to drive lifestyle change. This research is the largest multi-year study of digital therapy efficacy in controlling hypertension.

Michael Gutman (from SY) CTO & amp;  CISO, Maayan Cohen, Co-Founder and CEO, and Ziv Meltzer, Co-Founder, Chief Design.  Photo: Hello Heart Michael Gutman (from left) CTO and CISO, Maayan Cohen, Co-Founder and CEO, and Ziv Meltzer, Co-Founder, Chief Design. Photo: Hello Heart

Researchers tracked 28,189 adults with health insurance using Hello Heart technology and programs. These include the fact that more and more people are busy with Halo digital digital therapy, and that their blood pressure improves, especially in those with stage II, the most severe form of hypertension.

“This is the first peer-reviewed, published study reporting the long-term experience of digital health applications for blood pressure management, with the intensity of the association clinically meaningful,” said Alex Beatty, MD, MD. AS, a cardiologist and colleague said. Professor at the University of California, San Francisco, and lead author of the study. “On average, participants have used Hello Heart for 25 weeks, a level of engagement I have not seen in digital yen digital hypertension management programs. Continuous engagement and systolic blood pressure reduction of more than 20 mmHg can increase the chance of a person’s heart attack, stroke, kidney disease and death.

Researchers found that for the majority of users, any level of engagement with the Halo Heart program was associated with a decrease in blood pressure. Furthermore, Hello Heart demonstrated the ability to capture hypertension crises in men and women and to destabilize them before timely identification of potential events. The results were statistically significant even after adjusting for demographic, socioeconomic status, and behavioral factors.

“There is a lot of skepticism and hypocrisy around hypertension management solutions because for years, no effective solution has been found, and current solutions produce less participant engagement. We are pleased that the study has shown strong clinical results that have been sustained for three years for Hello Heart users, ”said Maian Cohen, CEO of Helve Heart. “It can be very uncomfortable and frightening for companies to submit their results to peer review. We have been helping consumers’ heart health for many years and are proud of their clinical results through a peer-review process that confirms what we already have ates – hello strong to the heart , Has a sustainable clinical impact.

Source link